thisdrug what a medicine's name tells you

WHO naming stem · suffix · 54 listed names

-adol/-adol-

This page was written with AI.

analgesics

WHO's definition, quoted as written in the 2024 stem book

4 of 54 names appear in these lists: 3 in the US list (FDA Drugs@FDA) and 2 in the EU central list (EMA); 2 have national brands in at least one EU/EEA country.

Names only. This page is about -adol/-adol- as a part of a name. It has nothing on uses, doses, side effects or interactions of any medicine that carries it, and nothing here is medical advice. Ask a pharmacist or doctor about the medicine itself.

Where it sits in a name

WHO writes the stem as -adol/-adol-. It has 2 spellings or places: adol at the end of the name (…adol); adol inside the name, with letters before and after it (…adol…).

Of the 54 names WHO lists under it, 39 carry adol at the end of the name, 15 carry adol inside the name, with letters before and after it.

All 54 names WHO lists under -adol/-adol-

These are the INN in group (a) of Part IV of the stem book: names in which WHO says the stem is used as defined. The stem is marked where WHO places it. A-Z as WHO lists them.

Beside each name: the brand names it appears under in the US list (FDA Drugs@FDA) and the EU central list (EMA), or that neither list carries it. 4 of 54 names appear in these lists: 3 in the US list (FDA Drugs@FDA) and 2 in the EU central list (EMA); 2 have national brands in at least one EU/EEA country. Each brand opens in this site's brand lookup. A name is found when the agency's ingredient name is the same name once salt words such as hydrochloride or sodium are set aside (the list of those words); where WHO's own name carries such a word (estradiol valerate), the agency must write the same words. A spelling that differs only by the INN letter rules (ph for f, y for i) is found too and shown. Under each name that one or more EU/EEA countries authorise under a national brand of their own (through that country's agency, so not in the EU central list), a line now gives the number of those countries and their codes, from EMA's Article 57 data, and opens the country lookup at that name. A name with none of these lines may still be sold elsewhere, or in Europe only under its own generic name.

  1. acetylmethadol
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  2. alimadol
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  3. alphacetylmethadol
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  4. alphamethadol
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  5. apadoline
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  6. asimadoline
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  7. axomadol
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  8. befiradol
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  9. betacetylmethadol
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  10. betamethadol
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  11. bromadoline
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  12. cebranopadol
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  13. ciprefadol
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  14. ciramadol
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  15. cloracetadol
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  16. desmetramadol
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  17. dibusadol
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  18. dimenoxadol
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  19. diproxadol
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  20. eluxadoline
    US brands: VIBERZI
    EU (central) brands: Truberzi (withdrawn)
  21. enadoline
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  22. faxeladol
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  23. filenadol
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  24. flumexadol
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  25. fluradoline
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  26. gaboxadol
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  27. indantadol
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  28. insalmadol
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  29. levacetylmethadol
    US brands: none found
    EU (central) brands: Orlaam (withdrawn)
  30. levonantradol
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  31. lexanopadol
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  32. lorcinadol
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  33. moxadolen
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  34. myfadol
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  35. nafoxadol
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  36. nantradol
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  37. nerbacadol
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  38. noracymethadol
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  39. oxapadol
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  40. picenadol
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  41. pinadoline
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  42. pipradimadol
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  43. pipramadol
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  44. pravadoline
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  45. profadol
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  46. radolmidine
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  47. ruzadolane
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  48. spiradoline
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  49. tapentadol
    US brands: NUCYNTA, NUCYNTA ER
    EU (central) brands: none found
  50. tazadolene
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  51. tolpadol
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  52. tramadol
    US brands: CONZIP, QDOLO (discontinued in FDA listings), RYBIX ODT (discontinued in FDA listings), RYZOLT (discontinued in FDA listings), ULTRAM (discontinued in FDA listings), ULTRAM ER (discontinued in FDA listings)
    in combination: SEGLENTIS (discontinued in FDA listings) with celecoxib; ULTRACET (discontinued in FDA listings) with acetaminophen
    EU (central) brands: none found
  53. vadoline
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  54. veradoline
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)

US list: Drugs@FDA, from the FDA Drugs@FDA data (openFDA bulk file), checked . It keeps discontinued brands, marked here as FDA marks them.

EU (central) list: EMA medicines list, European Medicines Agency (EMA), checked . Medicines authorised for the whole EU through EMA only: a brand authorised by one country's own agency is not in it. Source: European Medicines Agency (EMA), medicines list, checked 2026-09-24.

EU/EEA national lists: European Medicines Agency (EMA), Article 57 product data, downloaded (EMA's Article 57 page). Brand names authorised by each country's own agency, as the country lookup reads them; a product named after its substance and maker ("Paracetamol Teva") is not counted as a brand, and EU central authorisations are not counted as a country. GB in a list is Northern Ireland, which EMA's data carries alongside the EU/EEA countries.

Names with these letters that are not analgesics

WHO lists these 4 names under -adol/-adol-, but says the stem is not used in its meaning here: group (b) of Part IV of the 2024 stem book, “INN in which the preferred stem has been used, but not in accordance with its definition”. The letters are marked where they sit; WHO’s note, where it gives one, is quoted as written. In these names, WHO’s definition of -adol/-adol- does not apply.

  1. alfadolone
  2. hexapradolWHO’s note: CNS stimulant
  3. nadolol
  4. quinestradolWHO’s note: estrogenic

Same group, without the stem

WHO also lists this name under -adol/-adol-: group (c) of Part IV of the 2024 stem book, “INN which belong to the same group of pharmaceutical substances but in which the stem is not used”. It belongs to the same group of substances as the group (a) names above, yet it does not carry -adol/-adol-, so the name alone does not reveal the group.

  1. dimepheptanol

Decode another name

Decoded

myfadol

Listed INNCarries the WHO stem -adol/-adol-

  • -adol/-adol-end of the nameWHO lists it hereWHO definition: analgesics

“myfadol” is an INN that WHO lists under -adol/-adol- in the 2024 stem book.

The same decoder as the front page: it reads the letters of a name against all 482 WHO stems, in your browser.

Source and licence

The definition of -adol/-adol- (Part II B) and the 54 names (Part IV, group (a)), and the 4 not in accordance with it (group (b)) and 1 of the same group without the stem (group (c)) are from Use of stems in the selection of International Nonproprietary Names (INN) for pharmaceutical substances, 2024 (World Health Organization, Stem book 2024 (ISBN 978-92-4-009938-8); covers proposed INN Lists 1-129). Checked .

Adapted from: Use of stems in the selection of International Nonproprietary Names (INN) for pharmaceutical substances, 2024. Geneva: World Health Organization; 2024. Licence: CC BY-NC-SA 3.0 IGO. This adaptation was not created by WHO; WHO is not responsible for its content or accuracy and does not endorse this site. The data file stems.json is shared under the same licence.

Made with AI tools. · Privacy